Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
2007

WNT Signaling and Breast Cancer Cell Growth

publication 10 minutes Evidence: moderate

Author Information

Author(s): Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E Hynes

Primary Institution: Friedrich Miescher Institute for Biomedical Research

Hypothesis

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

Conclusion

Interference with autocrine WNT signaling in human breast cancer reduces proliferation and survival of human breast cancer cells.

Supporting Evidence

  • Blocking WNT signaling reduced breast cancer cell proliferation by 30% to 60%.
  • Active β-catenin levels decreased with WNT pathway interference.
  • EGFR activity was shown to be linked to WNT signaling in breast cancer cells.

Takeaway

This study shows that a signaling pathway called WNT helps breast cancer cells grow, and blocking it can make the cancer cells stop growing.

Methodology

The study used cell counting, YOPRO, and MTT assays to measure proliferation, and Western blotting to assess signaling pathway activation.

Limitations

The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1769

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication